From AVAC <[email protected]>
Subject Jan 19 Webinar: Oral PrEP Implementation and Implications for Next Generation PrEP
Date January 14, 2022 7:59 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** Webinar: Oral PrEP Implementation and Implications for Next Generation PrEP
------------------------------------------------------------
January 14, 2022

Dear Advocate,

Join AVAC and partners Wednesday, January 19 ([link removed]) at 8-9:30 am EST ([link removed]) , as we share critical insights and lessons from oral PrEP programs in Kenya, South Africa, and Zimbabwe. Learning from these efforts, and other key lessons from oral PrEP introduction ([link removed]) to date, is essential to faster, smarter and more affordable rollout of future HIV prevention products, including the Dapivirine Vag ([link removed]) inal Ring ([link removed]) and injectable cabotegravir ([link removed]) . These lessons are built on more than six years of analysis and collaboration with partners and reflect urgent priorities for the field. The world cannot afford to make the same mistakes twice as a growing number of tools for prevention gain regulatory approval.

Click here to register for Insights from Oral PrEP Implementation and Implications for Next Generation PrEP ([link removed]) . You’ll hear Saiqa Mullick of WitsRHI ([link removed]) , Joseph Murungu of Pangaea Zimbabwe AIDS Trust ([link removed]) (PZAT), and Daniel Were ofJhpiego ([link removed]) discuss what has worked and what
must change to transform options into choices, to finally reach the targets that will end the epidemic of HIV.

These insights offer a unique opportunity to fulfill the potential of HIV biomedical prevention, demonstrate the impact of informed choice, and realize the full benefits of increasing the use of HIV prevention among those who need it most. As additional PrEP options come to market ([link removed]) , they could transform the landscape of HIV prevention—offering more personalized options, increasing the number of PrEP users, and ultimately contributing to lower HIV incidence. These products must be accessible, acceptable and used effectively by those who need them.

This webinar follows the important discussion AVAC convened yesterday, where leading voices in the field of HIV prevention identified their priorities in 2022. Check out the recording of Ups & Downs in the Field: Setting an agenda together for 2022 ([link removed]) , andjoin the January 19th discussion ([link removed]) to focus on next steps for these priorities on getting rollout right in 2022.

Best,
AVAC

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis